Your Messages Inbox
Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. AHA Guidelines on Cardiac CT for Assessing Coronary Artery Disease 3. Rapid correction of low vitamin D status in nursing home residents 4. 2008 Exclusive Survey—Earnings: Good news for primary care income 5. Medicare pay-for-reporting effort draws fire from frustrated doctors
Your Article Summary
See Latest ArticlesPreoperative chemoradiation in potentially resectable pancreatic adenocarcinoma: feasibility, treatment effect evaluation and prognostic factors, analysis of the SFRO-FFCD 9704 trial and literature review
Annals of Oncology, 06/09/09
Le Scodan R et al. - In a study to explore the feasibility and the histologic assessment of treatment effect of preoperative chemoradiation in pts presenting with resectable pancreatic adenocarcinoma, it was found that this proposed preoperative scheme is feasible, does not prevent successful surgery, and provides antitumoral effect associated with major histopathological response in 50% of pts and a high R0 resection rate.
Methods- Treatment consisted of concurrent radiotherapy (50 Gy within 5 wks) and chemotherapy with 5-fluorouracil (300 mg/m2/day, 5 days/wk, wks 1–5) and cisplatin (20 mg/m2/day, days 1–5 and 29–33), followed by surgical resection of pancreatic tumor in pts without progression.
- 41 pts were enrolled; 38 (93%) received 47 Gy; 30 pts (73%) received 75% of the prescribed doses of chemotherapy.
- Among 40 assessable pts, 27 (67.5%) were successfully treated (entire dose of radiation, 75% of the chemotherapy dose, no grade 4 non-hematologic toxicity).
- 26 pts (63%) underwent surgical resection with curative intent and 21 (80.7%) had R0 resection.
- 13 of 26 specimens (50%) presented a major pathologic response (80% of severely degenerative cancer cells), with 1 complete pathologic response.
- Operative mortality was 2.8%.
- Local recurrence and 2-yr survival rates were 4% and 32%, respectively, for the 26 operated pts.
Related Articles
Preoperative Diabetes Mellitus and Long-Term Survival After Resection of Pancreatic Adenocarcinoma
Annals of Surgical Oncology, 11/09/09
Relevance Score: 79%
Molecular markers associated with lymph node metastasis in pancreatic ductal adenocarcinoma by genome-wide expression profiling
Cancer Science, 10/28/09
Relevance Score: 79%
Actinin-4 Expression in Primary and Metastasized Pancreatic Ductal Adenocarcinoma
Pancreas, 10/27/09
Relevance Score: 79%
HuR modulates gemcitabine efficacy: new perspectives in pancreatic cancer treatment
Expert Review of Anticancer Therapy, 10/26/09
Relevance Score: 79%
Resectable Pancreatic Adenocarcinoma: Is the Enhancement Pattern at Contrast-Enhanced Ultrasonography a Pre-Operative Prognostic Factor
Ultrasound in Medicine and Biology, 10/16/09
Relevance Score: 79%
Today in Endocrine Oncology...keeping you current
Receive free subspecialty "5-minute updates" via email
Oncocytic versus mitochondrion-rich follicular thyroid tumours: should we make a difference
Histopathology, 12/04/09
CD98 expression is decreased in papillary carcinoma of the thyroid and Hashimotos thyroiditis
Histopathology, 12/04/09
Absence of Peritumoral Fibrosis or Inflammatory Infiltrate May Be Related to Clinical Progression of Papillary Thyroid Microcarcinoma
International Journal of Surgical Pathology, 12/03/09
Sponsor
Article Search
Sponsor